WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 1.8% of their position (2.90K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $4.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/20/2023ACC: 0001213900-23-088890
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+2.90K
Net shares
Net buyer
$4.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2.90K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.10K
Price / share
$1.33
Trade value
$1.46K
% of position
0.7%
11/16/2023
157.22K→158.32K
Common Stock
Direct
Shares
+1.80K
Price / share
$1.54
Trade value
$2.77K
% of position
1.1%
11/17/2023
158.32K→160.12K
Total
Net shares
+2.90K
Net value
$4.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/16/2023 | P · Purchase | +1.10K | $1.33 | $1.46K | 0.7% | 157.22K | 158.32K |
| Common Stock Direct | 11/17/2023 | P · Purchase | +1.80K | $1.54 | $2.77K | 1.1% | 158.32K | 160.12K |
| Total | +2.90K | $4.24K | ||||||
Derivative Transactions0
No derivative transactions reported